| Financial Year |
March 31 2023 |
| Monetary Funds |
908,687,379.94 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,750,500.00 |
| Accounts Receivable |
12,274,245.58 |
| Advances to Suppliers |
227,081,152.51 |
| Other Receivables |
42,776,722.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
13,294,709.46 |
| Inventories |
175,649,262.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
221,174,467.82 |
| Total Current Assets |
1,612,048,847.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
360,598,228.69 |
| Investment Properties |
636,725.22 |
| Fixed Assetes |
326,574,782.58 |
| Under-construction Projects |
98,076,710.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
130,121,557.56 |
| R&D expenses |
26,000.00 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,661,560.75 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
919,485,971.51 |
| Total Assets |
2,531,534,818.64 |
| Short-Term Loans |
1,117,743,651.79 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,000,000.00 |
| Accounts Payable |
126,252,549.47 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,269,766.15 |
| Taxes Payable |
2,512,612.25 |
| Interest Payable |
-- |
| Dividend Payable |
7,236.04 |
| Other payables |
116,287,936.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
438,966.47 |
| Other Current Liabilities |
164,291,777.50 |
| Sub-Total of Current Liabilities |
1,698,356,914.35 |
| Long-term Loans |
45,607,377.30 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,952,137.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
10,614,387.85 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
74,585,386.39 |
| Total Liabilities |
1,772,942,300.74 |
| Paid-In Capital(Or Share Stock) |
581,376,960.00 |
| Capital Surplus |
1,251,757,951.51 |
| Surplus Reserve |
41,092,499.14 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,083,494,812.22 |
| Minority Stockholder's Interest |
-32,140,080.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
790,732,598.43 |
| Owner's Equity（Stockholder's Equity） |
758,592,517.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,531,534,818.64 |
